Antiretroviral Recommendations May Influence the Rate of Transmission of Drug‐Resistant HIV Type 1
Open Access
- 15 July 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (2) , 227-232
- https://doi.org/10.1086/431203
Abstract
Background. Human immunodeficiency virus (HIV) treatment guidelines have evolved, shifting from more-aggressive to more-conservative approaches. TheKeywords
This publication has 41 references indexed in Scilit:
- The Case for Earlier Treatment of HIV InfectionClinical Infectious Diseases, 2004
- Treatment for Adult HIV InfectionJAMA, 2004
- Risk Behavior for Transmission of Human Immunodeficiency Virus (HIV) among HIV‐Seropositive Individuals in an Urban SettingClinical Infectious Diseases, 2004
- Enhanced risk of HIV sexual transmission during structured treatment interruptionSexually Transmitted Infections, 2003
- Salvage Treatment with Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients Failing All Current Antiretroviral Drug FamiliesHIV Research & Clinical Practice, 2002
- Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responsesHIV Research & Clinical Practice, 2002
- Genotypic drug resistance during HIV-1 primary infection in France (1996–1999): frequency and response to treatmentAIDS, 2002
- Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in SpainAIDS, 2000
- Disease progression and survival following specific AIDS-defining conditionsAIDS, 1998
- Heterosexual Transmission of Human Immunodeficiency Virus: Variability of Infectivity throughout the Course of InfectionAmerican Journal of Epidemiology, 1998